Patents by Inventor Uwe Hermann

Uwe Hermann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12564666
    Abstract: The present invention relates to a method for temporarily interrupting an extracorporeal treatment of blood of a patient by use of a blood treatment apparatus. The method comprises activating or controlling a control device provided and configured to bring the blood treatment apparatus into a state in which the blood treatment session of the patient can be interrupted with the intention to continue the blood treatment session. The present invention further relates to a control device, a blood treatment apparatus, a digital storage means, a computer program product as well as a computer program.
    Type: Grant
    Filed: January 11, 2024
    Date of Patent: March 3, 2026
    Assignee: Fresenius Medical Care Deutschland GmbH
    Inventors: Uwe Hermann, Sabine Kipp, Christine Nachbaur-Sturm, Thomas Pusinelli, Martin Gruendken, Georg Verch
  • Publication number: 20240139397
    Abstract: The present invention relates to a method for temporarily interrupting an extracorporeal treatment of blood of a patient by use of a blood treatment apparatus. The method comprises activating or controlling a control device provided and configured to bring the blood treatment apparatus into a state in which the blood treatment session of the patient can be interrupted with the intention to continue the blood treatment session. The present invention further relates to a control device, a blood treatment apparatus, a digital storage means, a computer program product as well as a computer program.
    Type: Application
    Filed: January 11, 2024
    Publication date: May 2, 2024
    Inventors: Uwe Hermann, Sabine Kipp, Christine Nachbaur-Sturm, Thomas Pusinelli, Martin Gruendken, Georg Verch
  • Patent number: 11918724
    Abstract: This disclosure relates to a method for temporarily interrupting an extracorporeal treatment of blood of a patient by use of a blood treatment apparatus. The method comprises activating or controlling a control device provided and configured to bring the blood treatment apparatus into a state in which the blood treatment of the patient can be interrupted with the intention to continue the blood treatment. This disclosure further relates to a control device, a blood treatment apparatus, a digital storage means, a computer program product as well as a computer program.
    Type: Grant
    Filed: June 20, 2017
    Date of Patent: March 5, 2024
    Assignee: Fresenius Medical Care Deutschland GmbH
    Inventors: Uwe Hermann, Sabine Kipp, Christine Nachbaur-Sturm, Thomas Pusinelli, Martin Gruendken, Georg Verch
  • Publication number: 20170312418
    Abstract: This disclosure relates to a method for temporarily interrupting an extracorporeal treatment of blood of a patient by use of a blood treatment apparatus. The method comprises activating or controlling a control device provided and configured to bring the blood treatment apparatus into a state in which the blood treatment of the patient can be interrupted with the intention to continue the blood treatment. This disclosure further relates to a control device, a blood treatment apparatus, a digital storage means, a computer program product as well as a computer program.
    Type: Application
    Filed: June 20, 2017
    Publication date: November 2, 2017
    Inventors: Uwe Hermann, Sabine Kipp, Christine Nachbaur-Sturm, Thomas Pusinelli, Martin Gruendken, Georg Verch
  • Patent number: 5384247
    Abstract: A process and a reagent for the determination of ions in fluids, wherein the influence of these ions on the activity of an enzyme is measured. The ions for example are sodium, potassium, calcium, magnesium, manganese, lithium, lead, zinc, copper, iron or other heavy metals or non-metallic ions comprising chloride, bicarbonate, protons, ammonium and substances that give rise to ammonium. The enzymes which are used may be a transferase, a hydrolase, an oxidoreductase or a lyase. An essential feature is a method to exclude interferences by ions by masking the interfering ions with a binding agent.
    Type: Grant
    Filed: June 22, 1992
    Date of Patent: January 24, 1995
    Assignees: Boehringer Mannheim, GmbH, The Flinders University of South Australia
    Inventors: Michael N. Berry, Michael-Harold Town, Georg-Burkhard Kresse, Uwe Hermann